ALC Stock Overview
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
Alcidion Group Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.12|
|52 Week High||AU$0.39|
|52 Week Low||AU$0.10|
|1 Month Change||-14.29%|
|3 Month Change||-7.69%|
|1 Year Change||-66.20%|
|3 Year Change||-53.40%|
|5 Year Change||126.42%|
|Change since IPO||84.62%|
Recent News & Updates
|ALC||AU Healthcare Services||AU Market|
Return vs Industry: ALC underperformed the Australian Healthcare Services industry which returned -22% over the past year.
Return vs Market: ALC underperformed the Australian Market which returned -10.8% over the past year.
|ALC Average Weekly Movement||10.6%|
|Healthcare Services Industry Average Movement||11.4%|
|Market Average Movement||9.4%|
|10% most volatile stocks in AU Market||16.5%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: ALC is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: ALC's weekly volatility (11%) has been stable over the past year.
About the Company
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services.
Alcidion Group Limited Fundamentals Summary
|ALC fundamental statistics|
Is ALC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|ALC income statement (TTM)|
|Cost of Revenue||AU$4.86m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.0035|
|Net Profit Margin||-12.84%|
How did ALC perform over the long term?See historical performance and comparison